SCHEMBL17280352

SCHEMBL17280352

COc1ccc(-c2c3c(c(O)c4cc(C)c(C)cc24)COC3=O)cc1OC

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.69
ALDH1A1 P00352 4/20 0.69
MAPT P10636 4/20 0.69
MEN1 O00255 4/20 0.69
KMT2A Q03164 4/20 0.69
NPSR1 Q6W5P4 2/20 0.69
LMNA P02545 2/20 0.69
HPGD P15428 2/20 0.69
HTT P42858 1/20 0.69
TOP2A P11388 1/20 0.50
CYP19A1 P11511 3/20 0.48
CASP1 P29466 3/20 0.42
CASP7 P55210 3/20 0.42
CYP3A4 P08684 2/20 0.42
TP53 P04637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ALOX5 P09917 1/20 0.42
PDE1A P54750 2/20 0.41
PDE1B Q01064 2/20 0.41
PDE3B Q13370 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15920967 0.94 KDM4E (0.77) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL4096679 0.90 KDM4E (0.85) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL17280327 0.87 MAPT (0.57) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL17280355 0.86 KDM4E (0.59) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL17339974 0.85 KDM4E (0.78) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL15920662 0.83 MAPT (0.72) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL15920749 0.83 ALDH1A1 (0.71) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL15920805 0.82 KDM4E (0.71) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL9538208 0.82 KDM4E (0.58) KDM4EALDH1A1MAPTMEN1KMT2A
Diphyllin SCHEMBL1061765 0.82 ALDH1A1 (1.00) KDM4EALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9650355-B2 Method for preparation of justicidin a derivatives of arylnaphthalene lignan structure KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-05-16 US disclosed
US-20150336938-A1 METHOD FOR PREPARATION OF JUSTICIDIN A DERIVATIVES OF ARYLNAPHTHALENE LIGNAN STRUCTURE KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336938-A1 METHOD FOR PREPARATION OF JUSTICIDIN A DERIVATIVES OF ARYLNAPHTHALENE LIGNAN STRUCTURE UGT1A8, NOTUM, MLN KDM4E 3104/4885ALDH1A1 241/4885MAPT 3028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.